Abstract
Gastroesophageal reflux disease (GERD) is one of the most common disease processes encountered worldwide and it causes significant impairment in patient’s quality of life. Endoscopic therapies have been developed to provide high-efficacy treatments for GERD with a low incidence of side effects. Transoral incisionless fundoplication (TIF) provides an endoscopic approach to rebuild the gastroesophageal flap valve and control reflux symptoms. This approach has been shown to improve patient symptoms and improve quality of life of patients suffering with GERD. In this chapter we discuss the indications, technique, risks, complications, and outcomes of TIF for the management of chronic GERD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710–7.
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28; quiz 329.
Triadafilopoulos G. Endoscopic options for gastroesophageal reflux: where are we now and what does the future hold? Curr Gastroenterol Rep. 2016;18(9):47.
Jain D, Singhal S. Transoral incisionless fundoplication for refractory gastroesophageal reflux disease: where do we stand? Clin Endosc. 2016;49(2):147–56.
Trad KS, Simoni G, Barnes WE, Shughoury AB, Raza M, Heise JA, et al. Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study. BMC Gastroenterol. 2014;14:174.
Trad KS, Barnes WE, Simoni G, Shughoury AB, Mavrelis PG, Raza M, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial. Surg Innov. 2015;22(1):26–40.
Trad KS, Fox MA, Simoni G, Shughoury AB, Mavrelis PG, Raza M, et al. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm. Surg Endosc. 2017;31(6):2498–508.
Hunter JG, Kahrilas PJ, Bell RC, Wilson EB, Trad KS, Dolan JP, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–333.e5.
EndoGastric Solutions I. EsophyX Device: Innovative Technology Making Transoral Reconstructive Surgery Possible. 2016.; https://www.endogastricsolutions.com/technology/esophyx-device/.
Bell RC, Cadiere GB. Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc. 2011;25(7):2387–99.
Testoni PA, Mazzoleni G, Testoni SG. Transoral incisionless fundoplication for gastro-esophageal reflux disease: techniques and outcomes. World J Gastrointest Pharmacol Ther. 2016;7(2):179–89.
Witteman BP, Conchillo JM, Rinsma NF, Betzel B, Peeters A, Koek GH, et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2015;110(4):531–42.
Hoppo T, Immanuel A, Schuchert M, Dubrava Z, Smith A, Nottle P, et al. Transoral incisionless fundoplication 2.0 procedure using EsophyX for gastroesophageal reflux disease. J Gastrointest Surg. 2010;14(12):1895–901.
Edriss H, El-Bakush A, Nugent K. Esophgeal perforation and bilateral empyema following endoscopic EsophyX Transoral incisionless fundoplication. Clin Endosc. 2014;47(6):560–3.
Titus JM, Mason DP, Raymond DP, Rice TW, Murthy SC. Esophagopulmonary fistula and left lung abscess after transoral incisionless fundoplication. Ann Thorac Surg. 2013;96(2):689–91.
Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev. 2006;4:CD004823.
Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol. 2011;106(8):1419–25; quiz 1426.
Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope. 2001;111(12):2147–51.
Trad KS, Barnes WE, Prevou ER, Simoni G, Steffen JA, Shughoury AB, et al. The TEMPO trial at 5 years: Transoral Fundoplication (TIF® 2.0) is safe, durable, and cost-effective. Surg Innov. 2018;25(2):149–57.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
About this chapter
Cite this chapter
Benham, E.C., Perry, K.A. (2020). Evaluation and Management of Patients with Gastroesophageal Reflux Disease (GERD): TIF/Plication Methods. In: Nau, P., Pauli, E., Sandler, B., Trus, T. (eds) The SAGES Manual of Flexible Endoscopy. Springer, Cham. https://doi.org/10.1007/978-3-030-23590-1_25
Download citation
DOI: https://doi.org/10.1007/978-3-030-23590-1_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23589-5
Online ISBN: 978-3-030-23590-1
eBook Packages: MedicineMedicine (R0)